Polyneuropathy is a common and important chemotherapy-induced adverse effect which often leads to dose modifications and impact on patients’ quality of life. Limited treatment options for prevention and management of this neuropathology stimulate further research on the topic. Recent attention has been focused on downregulation of glial glutamate transporter expression observed in spinal region of rodents treated with cancer chemotherapy drugs. Consequent extrasynaptic glutamate overflow could be considered a key element in neuropathic pathogenesis resulting in excessive activation of glutamate receptors and neuronal hyper-excitability, finally contributing to develop neuropathic condition. Recently, the onset of neuropathy in bortezomib treated rats could be prevented by preemptive administration of drugs promoting glial glutamate transporter expression and antagonism at mGlur5, a metabotropic receptor which reinforces glutamatergic transmission in presence of high extracellular glutamate concentrations. These findings point to glial-glutamate system dysregulation as a main mechanism in the pathogenesis of anticancer chemotherapy induced neuropathy.

GLUTAMATERGIC SYSTEM MODULATORS AS AGENTS IN PREVENTION AND MANAGEMENT OF CHEMOTHERAPY- INDUCED POLYNEUROPATHY / Ghelardini, C; Di Cesare Mannelli, L.; Cerretani, D.; Bianchi, E.. - In: THERAPEUTIC TARGETS FOR NEUROLOGICAL DISEASES. - ISSN 2376-0478. - STAMPA. - 2:e672:(2015), pp. 1-3. [10.14800/ttnd.672]

GLUTAMATERGIC SYSTEM MODULATORS AS AGENTS IN PREVENTION AND MANAGEMENT OF CHEMOTHERAPY- INDUCED POLYNEUROPATHY

GHELARDINI, CARLA;DI CESARE MANNELLI, LORENZO;
2015

Abstract

Polyneuropathy is a common and important chemotherapy-induced adverse effect which often leads to dose modifications and impact on patients’ quality of life. Limited treatment options for prevention and management of this neuropathology stimulate further research on the topic. Recent attention has been focused on downregulation of glial glutamate transporter expression observed in spinal region of rodents treated with cancer chemotherapy drugs. Consequent extrasynaptic glutamate overflow could be considered a key element in neuropathic pathogenesis resulting in excessive activation of glutamate receptors and neuronal hyper-excitability, finally contributing to develop neuropathic condition. Recently, the onset of neuropathy in bortezomib treated rats could be prevented by preemptive administration of drugs promoting glial glutamate transporter expression and antagonism at mGlur5, a metabotropic receptor which reinforces glutamatergic transmission in presence of high extracellular glutamate concentrations. These findings point to glial-glutamate system dysregulation as a main mechanism in the pathogenesis of anticancer chemotherapy induced neuropathy.
2015
2:e672
1
3
Ghelardini, C; Di Cesare Mannelli, L.; Cerretani, D.; Bianchi, E.
File in questo prodotto:
File Dimensione Formato  
review bianchi glutamate.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 104.99 kB
Formato Adobe PDF
104.99 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1061763
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact